Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00786539 · ClinicalTrials.gov registry record

Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases

A clinical trial, sponsored by University of California, Irvine.

Completed
Registry status
18
Enrollment target

NCT00786539 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00786539 has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders. This research study brings together many clinical sub-specialists to address the etiology of these disorders and to develop more effective approaches for their diagnoses and more reliable prognoses.

Interventions

  • DEVICE Diffuse Optical Spectroscopy

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2006-10
Est. Completion 2015-05

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT00786539

The ClinicalTrials.gov registry entry for NCT00786539 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.

NCT00786539 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00786539 about?

NCT00786539 is a clinical study titled "Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases". The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders. This research study brings together many clinical sub-specialists to address the e...

What is the current status of trial NCT00786539?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2006-10. Estimated completion is 2015-05.

What interventions are being tested in trial NCT00786539?

The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT00786539?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.